SonoVascular, Inc., a clinical stage medical device company focused on transforming the treatment of venous thromboembolism (VTE) with its SonoThrombectomy(TM) System, has completed the first close of ...

Avantec Vascular, a Nipro company, announced FDA 510(k) clearance of its thrombectomy system, which is intended for the treatme ...

SonoVascular announced today that it has completed the first close of its $6 million Series A financing round.

Deep vein thrombosis, or DVT, is a potentially life-threatening blood clotting condition. If you’ve ever had DVT or been at risk for this condition, you’ve likely been given drugs to help break up the ...

O’Sullivan is an interventional radiologist — a physician who specializes in minimally invasive, targeted treatments. In mid-March at the Society of Interventional Radiology scientific meeting in ...

The ALPHA-PE Research Fund is designed to support physician-led studies that advance understanding of pulmonary embolism and ...

Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after ...

Deep vein thrombosis (DVT) is a serious condition that occurs when a blood clot forms in a vein, often in the deep veins of the legs, thigh or pelvis. Those clots can break loose, travel to the lungs ...

The disadvantages of dabigatran include a higher cost compared with warfarin, the need for twice-daily dosing, and a slightly increased risk for gastrointestinal bleeding (6.1% with dabigatran vs 4% ...

LITTLE ROCK, AR (KATV) — Doctors are raising awareness about deep vein thrombosis (DVT), a condition that can lead to serious health risks, including life-threatening situations. Lindsey Williams, an ...

There are several superficial vein thrombosis treatment options. A person’s symptoms and overall health can influence the type of treatment they receive. Superficial vein thrombosis (SVT), also known ...

Researchers sought to determine whether vaccination against COVID-19 would increase the risk of developing deep vein thrombosis. The following article features coverage from the American Society of ...